Hematology/Oncology
Galle P, Finn RS, Mitchell CR, Ndirangu K, Ramji Z, Redhead GS, Pinato DJ. Treatment-emergent antidrug antibodies related to PD-1, PD-L1, or CTLA-4 inhibitors across[...]
Sasine JP, Kozlova NY, Valicente L, Dukov J, Tran DH, Himburg HA, Kumar S, Khorsandi S, Chan A, Grohe S, Li M, Kan J, Sehl[...]
Ayala Ceja M, Khericha M, Harris CM, Puig-Saus C, Chen YY. CAR-T cell manufacturing: Major process parameters and next-generation strategies. J Exp Med. 2024 Feb[...]
Abida W, Hahn AW, Shore N, Agarwal N, Sieber P, Smith MR, Dorff T, Monk JP, Rettig MB, Patel R, Page A, Duff M, Xu[...]
Borghaei H, de Marinis F, Dumoulin D, Reynolds C, Theelen WSME, Percent I, Gutierrez Calderon V, Johnson ML, Madroszyk-Flandin A, Garon EB, He K, Planchard[...]
Lee J, Boas EF, Duran-Struuk R, Gaba R, Schachtschneider KM, Comin-Anduix B, Galic Z, Haile S, Bassir A, Chiang J. Pigs as clinically relevant models[...]
Ravi S, Shanahan MJ, Levitt B, Harris KM, Cole SW. Socioeconomic inequalities in early adulthood disrupt the immune transcriptomic landscape via upstream regulators. Sci Rep.[...]
Sepucha K, Rudkin A, Baxter-King R, Stanton AL, Wenger N, Vavreck L, Naeim A. Perceptions of COVID-19 Risk: How Did People Adapt to the Novel[...]
Llovet JM, Cappuyns S, Finn RS. HIMALAYA Overall Survival Prominence and Other Routes to the Peak-Reply. JAMA Oncol. 2024 Jan 11. doi: 10.1001/jamaoncol.2023.6271. Epub ahead[...]
Wu TC, Luterstein E, Neilsen BK, Goldman JW, Garon EB, Lee JM, Felix C, Cao M, Tenn SE, Low DA, Kupelian PA, Steinberg ML, Lee[...]